Evidence map›Paper›PMID 24751986›Full record

ArticlePloS one2014

Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments.

He Li, Caroline Fitchett, Katarzyna Kozdon, Hari Jayaram, Geoffrey E Rose, Maryse Bailly, Daniel G Ezra

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Identifying Phenotypically Distinct Fibroblast Subsets in Type 2 Diabetes-Associated Iatrogenic Laryngotracheal Stenosis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Fibrosis in dysthyroid eye disease.Eye (London, England) · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

He LiDepartment of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom.
Caroline FitchettDepartment of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom.
Katarzyna KozdonDepartment of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom.
Hari JayaramDepartment of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom.
Geoffrey E RoseDepartment of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom; Moorfields Eye Hospital, and the National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, UCL Partners AHSC, London, United Kingdom.
Maryse BaillyDepartment of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom.
Daniel G EzraDepartment of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom; Moorfields Eye Hospital, and the National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, UCL Partners AHSC, London, United Kingdom.
University College London · GBNational Institute for Health Research · GB

Funding

Medical Research Council G0500927Medical Research Council G0801049
6 · The paper itself

Abstract

Graves' orbitopathy (GO) is a disfiguring and sometimes blinding disease, characterised by inflammation and swelling of orbital tissues, with fibrosis and adipogenesis being predominant features. Little is known about the disease aetiology and the molecular mechanisms driving the phenotypic changes in orbital fibroblasts are unknown. Using fibroblasts isolated from the orbital fat of undiseased individuals or GO patients, we have established a novel in vitro model to evaluate the dual profile of GO cells in a three-dimensional collagen matrix; this pseudo-physiological 3D environment allows measurement of their contractile and adipogenic properties. GO cells contracted collagen matrices more efficiently than control cells following serum or TGFβ1 stimulation, and showed a slightly increased ability to proliferate in the 3D matrix, in accordance with a fibro-proliferative phenotype. GO cells, unlike controls, also spontaneously differentiated into adipocytes in 3D cultures - confirming an intrinsic adipogenic profile. However, both control and GO cells underwent adipogenesis when cultured under pathological pressure levels. We further demonstrate that a Thy-1-low population of GO cells underlies the adipogenic - but not the contractile - phenotype and, using inhibitors, confirm that the contractile and adipogenic phenotypes are regulated by separate pathways. In view of the current lack of suitable treatment for GO, we propose that this new model testing the duality of the GO phenotype could be useful as a preclinical evaluation for the efficacy of potential treatments.

Indexed as

AdipogenesisModels, BiologicalAgedCells, CulturedExtracellular MatrixFemaleFibroblastsGraves OphthalmopathyHumansMaleMiddle AgedPhenotypePressureThy-1 AntigensThy-1 Antigens

Identifiers

PMID24751986
PMCPMC3994071
OpenAlexW2059042278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.